Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has participated in 38 clinical trials.
Therapeutic areas: Lymphoma, Brain and Central Nervous System Tumors, Thromboembolism.
Sponsors: Children's Oncology Group, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Radiation Therapy Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has 38 clinical trials on record. Their work covers Lymphoma, Brain and Central Nervous System Tumors, Thromboembolism.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.